Target Validation in Drug Discovery H 296 p. 06
内容
Presents a comprehensive framework for approaching target validation indrug discovery. This work begins with a description of enabling technologies,including aptamers, RNA interference, and proteomics. It, then, looks atbiologic drug development with discussion of lessons learned from suchwell-known cases as Erbitux, Herceptin, and Avastin.